Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Fatigue Improvement after Switching Multiple Sclerosis Treatment from Interferon-β to Glatiramer Acetate in Clinical Practice.
Poster 200 Demyelinating Polyneuropathy Post-Operatively in a Patient with Squamous Cell Carcinoma of the Tongue: A Case Report.
Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
Type 1 diabetes and susceptibility to multiple sclerosis: What is the truth?
Effects of high-speed power training on muscle strength and power in patients with multiple sclerosis.
A lesion topography-based approach to predict the outcomes of patients with multiple sclerosis treated with Interferon Beta.
Atypical Features in a Large Turkish Family Affected with Friedreich Ataxia.
An In Vitro Diagnostic for Multiple Sclerosis Based on C-peptide Binding to Erythrocytes.
Neonatal Maternal Separation Impairs Prefrontal Cortical Myelination and Cognitive Functions in Rats Through Activation of Wnt Signaling.
Multiple sclerosis patients need and want information on exercise promotion from healthcare providers: a qualitative study.
Prevalence of anti-SOX1 reactivity in various neurological disorders.
Plasticity of Th17 Cells in Autoimmune Kidney Diseases.
Comparison of myelin water fraction values in periventricular white matter lesions between MS and NMOSD.
Coping with Multiple Sclerosis Scale: Reconsideration of the Factorial Structure.
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome.
Neuromyelitis optica spectrum disorder coinciding with hematological immune disease: A case report.
Glucocorticoid receptor haplotypes conferring increased sensitivity (BclI and N363S) are associated with faster progression of multiple sclerosis.
Chronic lung disease and multiple sclerosis: Incidence, prevalence, and temporal trends.
Significant Contribution of Mouse Mast Cell Protease 4 in Early Phases of Experimental Autoimmune Encephalomyelitis.
Intrathecal T-cell clonal expansions in patients with multiple sclerosis.
Quantification of Gait Abnormalities in Healthy-Looking Multiple Sclerosis Patients (with Expanded Disability Status Scale 0-1.5).
Evaluation of APR1 Gene Expression in Candida albicans Strains Isolated From Patients With Multiple Sclerosis.
Pathological background of subcortical hyperintensities on diffusion-weighted images in a case of neuronal intranuclear inclusion disease.
The experience of transitioning from relapsing remitting to secondary progressive multiple sclerosis: views of patients and health professionals.
Pediatric multiple sclerosis: Perspectives from adolescents and their families.
Pages
« first
‹ previous
…
743
744
745
746
747
748
749
750
751
…
next ›
last »